Article

Biological Interactions of Graphene-Family Nanomaterials: An Interdisciplinary Review

Department of Pathology and Laboratory Medicine, Brown University , Providence, Rhode Island 02912, United States.
Chemical Research in Toxicology (Impact Factor: 3.53). 09/2011; 25(1):15-34. DOI: 10.1021/tx200339h
Source: PubMed

ABSTRACT

Graphene is a single-atom thick, two-dimensional sheet of hexagonally arranged carbon atoms isolated from its three-dimensional parent material, graphite. Related materials include few-layer-graphene (FLG), ultrathin graphite, graphene oxide (GO), reduced graphene oxide (rGO), and graphene nanosheets (GNS). This review proposes a systematic nomenclature for this set of Graphene-Family Nanomaterials (GFNs) and discusses specific materials properties relevant for biomolecular and cellular interactions. We discuss several unique modes of interaction between GFNs and nucleic acids, lipid bilayers, and conjugated small molecule drugs and dyes. Some GFNs are produced as dry powders using thermal exfoliation, and in these cases, inhalation is a likely route of human exposure. Some GFNs have aerodynamic sizes that can lead to inhalation and substantial deposition in the human respiratory tract, which may impair lung defense and clearance leading to the formation of granulomas and lung fibrosis. The limited literature on in vitro toxicity suggests that GFNs can be either benign or toxic to cells, and it is hypothesized that the biological response will vary across the material family depending on layer number, lateral size, stiffness, hydrophobicity, surface functionalization, and dose. Generation of reactive oxygen species (ROS) in target cells is a potential mechanism for toxicity, although the extremely high hydrophobic surface area of some GFNs may also lead to significant interactions with membrane lipids leading to direct physical toxicity or adsorption of biological molecules leading to indirect toxicity. Limited in vivo studies demonstrate systemic biodistribution and biopersistence of GFNs following intravenous delivery. Similar to other smooth, continuous, biopersistent implants or foreign bodies, GFNs have the potential to induce foreign body tumors. Long-term adverse health impacts must be considered in the design of GFNs for drug delivery, tissue engineering, and fluorescence-based biomolecular sensing. Future research is needed to explore fundamental biological responses to GFNs including systematic assessment of the physical and chemical material properties related to toxicity. Complete materials characterization and mechanistic toxicity studies are essential for safer design and manufacturing of GFNs in order to optimize biological applications with minimal risks for environmental health and safety.

Full-text preview

Available from: ncbi.nlm.nih.gov
  • Source
    • "Graphene also shows great promise in tissue regeneration applications [42] [43]. Derived from graphite, it consists of a two-dimensional sheet of carbon atoms arranged in a hexagonal lattice [44] [45]. Sayyar et al. has shown the incorporation of graphene increases both electrical conductivity and mechanical strength of PCL composites [34]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cartilage as a tissue in the body possesses a low regenerative capacity and is extremely difficult to repair. Today, treatment of cartilage injury, degeneration and defects presents critical clinical challenges, yet none of the currently available cartilage treatments provides a perfect solution. Since natural cartilage extracellular matrix is a nanoscaled structure, the main objective of this study is to design a novel biomimetic nanostructured cartilage construct via electrospinning and carbon nanomaterials for enhancing human bone marrow mesenchymal stem cell chondrogenic differentiation. For this purpose, we synthesized a carbon nanomaterial mixture, using a plasma arc discharge method, consisting of graphene nanoplatelets and single walled carbon nanotubes. This nanomaterial was then incorporated into electrospun polycaprolactone (PCL) microfibrous scaffolds, with and without an additional poly-l-lysine surface coating. Scaffolds were thoroughly characterized for both their biomimetic features and biocompatibility. Our results showed that our scaffolds with carbon nanomaterial have greatly improved mechanical properties and enhanced stem cell adhesion, proliferation and chondrogenic differentiation than PCL controls without carbon nanomaterials, and thus hold promise for improving cartilage formation in future in vivo studies and clinical applications.
    Full-text · Article · Feb 2016 · Carbon
  • Source
    • "Therefore the practical application and collection of GO sheets become difficult after adsorption process; meanwhile, the uncollected GO sheets will lead to serious health and environmental problems once they are released into the environment [6]. To overcome these problems, maybe the superparamagnetic GO (MGO) is a better alternative material because it combines the advantages of both superparamagnetic particle and GO. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In this work, a superparamagnetic Fe3O4-graphene oxide (MGO) nanocomposite was prepared by one-step chemical co-precipitation method, and characterized by transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS), vibrating sample magnetometer (VSM), powder X-ray diffraction (PXRD), Raman spectroscopy and nitrogen adsorption–desorption curve. The as-prepared MGO was used to adsorb nuciferine, and the adsorption kinetic, isotherm and reusability of MGO were also investigated. The results showed that the adsorption of nuciferine on MGO reached its equilibrium very quickly (within 10 min) due to the two-dimensional carbon nanostructure of GO. In comparison with MGO, five conventional sorbents, i.e., macroporous resin D-101, silica gel, reverse phase silica gel (RP-C18) and cation exchange resin and polyamide, were also used to evaluate their adsorption capabilities. Therefore, MGO combined the advantages of both superparamagnetic particle and GO, i.e., easy separation and high absorption capacity. Finally, MGO was successfully applied to enrichment and separation of nuciferine in the extract of Nelumbinis Folium (Lotus leaf).
    Full-text · Article · Dec 2015 · Applied Surface Science
    • "Lung deposition is mainly determined by the physical characteristics of the aerosol (size, density, shape, hygroscopicity ) in relation to airflow and the anatomy of the respiratory system . Nanoparticles with a primary/agglomerate size of b 100 nm, or an agglomerate size between 100 nm and 1 μm with a high density, will deposit efficiently in the alveolar region (Asgharian et al., 2009;Carvalho et al., 2011;Cassee et al., 2002;Donaldson et al., 2010;Geraets et al., 2012;Hinds, 1982;ICRP, 1994;Kreyling et al., 2009;Landsiedel et al., 2010;Noel et al., 2012;Oberdorster et al., 1994Oberdorster et al., , 2000Sanchez et al., 2012;Varghese and Gangamma, 2009). Nonhygroscopic nanoparticles will not grow in size by water uptake, resulting in a higher chance to reach the alveoli (Varghese and Gangamma, 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The rapidly expanding manufacturing, production and use of nanomaterials has raised concerns for both worker and consumer safety. Various studies have been published in which induction of pulmonary inflammation after inhalation exposure to nanomaterials has been described. Nanomaterials can vary in aspects such as size, shape, charge, crystallinity, chemical composition, and dissolution rate. Currently, efforts are made to increase the knowledge on the characteristics of nanomaterials that can be used to categorise them into hazard groups according to these characteristics. Grouping helps to gather information on nanomaterials in an efficient way with the aim to aid risk assessment. Here, we discuss different ways of grouping nanomaterials for their risk assessment after inhalation. Since the relation between single intrinsic particle characteristics and the severity of pulmonary inflammation is unknown, grouping of nanomaterials by their intrinsic characteristics alone is not sufficient to predict their risk after inhalation. The biokinetics of nanomaterials should be taken into account as that affects the dose present at a target site over time. The parameters determining the kinetic behaviour are not the same as the hazard-determining parameters. Furthermore, characteristics of nanomaterials change in the life-cycle, resulting in human exposure to different forms and doses of these nanomaterials. As information on the biokinetics and in situ characteristics of nanomaterials is essential but often lacking, efforts should be made to include these in testing strategies. Grouping nanomaterials will probably be of the most value to risk assessors when information on intrinsic characteristics, life-cycle, biokinetics and effects are all combined.
    No preview · Article · Nov 2015 · Toxicology and Applied Pharmacology
Show more